Patient info Open main menu

Amitriptyline 25 mg tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
25 mg
Contains active substance:

Patient leaflet - Amitriptyline 25 mg tablets

1. What Amitriptyline Tablets are and what they are used for

Amitriptyline belongs to a group of medicines called tricyclic antidepressant drugs. These medicines alter the levels of chemicals in the brain to relieve the symptoms of depression. Amitriptyline is used to treat:

  • Depression in adults (major depressive episodes)
  • Neuropathic pain in adults
  • Chronic tension type headache prophylaxis in adults
  • Migraine prophylaxis in adults
  • Bed-wetting at night in children aged 6 years and

    above, only when organic causes, such as spina bifida and related disorders, have been excluded and no response has been achieved to all other non-drug and drug treatments, including muscle relaxants and desmopressin. This medicine should only be prescribed by doctors with expertise in treating patients with persistent bed-wetting.

2. What you need to know before you take Amitriptyline Tablets

Do not take Amitriptyline Tablets if you:

  • are allergic (hypersensitive) to Amitriptyline, other

    tricyclic antidepressants or any of the other ingredients of this medicine (listed in section 6).

  • have heart problems such as irregular heart beats,

    heart block or failure, coronary artery disease

  • recently have had a heart attack (myocardial infarction)
  • have severe liver disease
  • are taking medicines known as monoamine oxidase

    inhibitors (MAOIs)

  • are taking monoamine oxidase inhibitors within the

    previous 14 days for depression

  • if the child is under 6 years old
  • have taken moclobemide the day before.
  • are treated with Amitriptyline Tablets, you have to

    stop taking this medicine and wait for 14 days before you start treatment with a MAOI.

Warnings and precautions

Talk to your doctor or pharmacist or nurse before taking Amitriptyline Tablets if you have:

  • Heart rhythm disorders and hypotension may occur

    if you receive a high dosage of Amitriptyline. This might also occur in usual doses if you have pre-existing heart disease.

  • Used Buprenorphine or Buprenorphine/naloxone

    together with Amitriptyline Tablets can lead to serotonin syndrome, a potentially life-threatening condition (see “Other medicines and Amitriptyline Tablets).

Take special care with Amitriptyline Tablets: Serious cutaneous reactions including drug reaction with eosinophilia and systemic symptoms (DRESS) have

been reported in association with amitriptyline tablets treatment. Stop using amitriptyline tablets and seek medical attention immediately if you notice any of the symptoms related to these serious cutaneous reactions described in section 4.

Prolonged QT interval

A heart problem called "prolonged QT interval" (which is shown on your electrocardiogram, ECG) and heart rhythm disorders (rapid or irregular heart beat) have been reported with Amitriptyline Tablets. Tell your doctor if you:

  • have slow heart rate,
  • have or had a problem where your heart cannot

    pump the blood round your body as well as it should (a condition called heart failure),

  • are taking any other medication that may cause

    heart problems, or

  • have a problem that gives you a low level of

    potassium or magnesium, or a high level of potassium in your blood.

  • have a surgery planned as it might be necessary to

    stop the treatment with Amitriptyline before you are given anaesthetics. In the case of acute surgery, the anaesthetist should be informed about the treatment of Amitriptyline.

  • have an over active thyroid gland or receive thyroid

    medication.

Thoughts of suicide and worsening of your depression If you are depressed, you can sometimes have thoughts of harming or killing yourself. These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.

You may be more likely to think like this:

  • If you have previously had thoughts about killing or

    harming yourself.

  • If you are a young adult. Information from clinical

    trials has shown an increased risk of suicidal behaviour in young adults (less than 25 years old) with psychiatric conditions who were treated with an antidepressant.

If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.

You may find it helpful to tell a relative or close friend that you are depressed, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.

Episodes of mania

Some patients with manic-depressive illness may enter into a manic phase. This is characterized by profuse and rapidly changing ideas, exaggerated gaiety and excessive physical activity. In such cases, it is important to contact your doctor who probably will change your medication.

Tell your doctor if you have, or have had in the past, any medical problems, especially if you have

  • narrow angle glaucoma (loss of vision due to

    abnormally high pressure in the eye)

  • epilepsy, a history of convulsions or fits
  • difficulty in passing urine
  • enlarged prostate
  • thyroid disease
  • bipolar disorder
  • schizophrenia
  • severe liver disease
  • severe heart disease
  • pylorus stenosis (narrowing of the gastric outlet)

    and paralytic ileus (blocked intestine)

  • diabetes as you might need an adjustment of your

    antidiabetic medicine.

body), white cells (which help to fight infection) and platelets (which help with clotting).

Rare side effect, may affect up to 1 in 1,000 people.

  • Suicidal thoughts or behaviour.

Side effects listed below have been reported in the following frequencies:

Very common: may affect more than 1 in 10 people

  • sleepiness/drowsiness
  • shakiness of hands or other body parts
  • dizziness
  • headache
  • irregular, hard, or rapid heartbeat
  • dizziness when you stand up due to low blood

    pressure (orthostatic hypotension)

  • dry mouth
  • constipation
  • nausea
  • excessive sweating
  • weight gain
  • slurred or slow speech
  • aggression
  • congested nose.

Common: may affect up to 1 in 10 people

  • confusion
  • sexual disturbances (decreased sex-drive, problems

    with erection)

  • disturbance in attention
  • changes in taste
  • numbness or tingling in the arms or legs
  • disturbed coordination
  • dilated pupils
  • heart block
  • fatigue
  • low sodium concentration in the blood
  • agitation
  • urination disorders
  • feeling thirsty.

Uncommon: may affect up to 1 in 100 people

  • excitement, anxiety, difficulties sleeping, nightmares
  • convulsions
  • tinnitus
  • increased blood pressure
  • diarrhoea, vomiting
  • skin rash, nettle rash (urticarial), swelling of the face

    and tongue

  • difficulties passing urine
  • increased production of breast milk or breast milk

    outflow without breast feeding

  • increased pressure in the eye ball, attach of intermittent

    blurred vision, rainbow vision, and eye pain

  • collapse conditions
  • worsening of cardiac failure
  • liver function impairment (e.g. cholestatic liver disease).

Rare: may affect up to 1 in 1,000 people

  • decreased appetite
  • delirium (especially in elderly patients), hallucinations,
  • abnormality in the heart's rhythm, or heartbeat

    pattern

  • swelling of the salivary glands
  • hair loss
  • increased sensitivity to sunlight
  • breast enlargement in men
  • fever
  • weight loss
  • abnormal results of liver function tests.

Very rare: may affect up to 1 in 10,000 people

  • heart muscle disease
  • feeling of inner restlessness and a compelling need

    to be in constant motion

  • disorder of the peripheral nerves
  • acute increase of pressure in the eye
  • particular forms of abnormal heart rhythm (so

    called torsades de pointes)

  • allergic inflammation of the lung alveoli and of the

    lung tissue.

Not known: frequency cannot be estimated from the available data

  • absent sensation of appetite
  • elevation or lowering of blood sugar levels
  • paranoia
  • movement disorders (involuntary movements or

    decreased movements)

  • hypersensitivity inflammation of heart muscle
  • an inflammation of the liver

    If you use antidepressants such as SSRIs, your doctor might consider changing the dose of your medicine (see also section 2, “Other medicines and Amitriptyline Tablets” and section 3).

    Elderly are more likely to suffer from certain side effects, such as dizziness when you stand up due to low blood pressure (see also section 4, “Possible side effects”).

    Children and adolescents

    Depression, neuropathic pain, chronic tension type headache and migraine prophylaxis.

    Do not give this medicine to children and adolescents aged below 18 years for these treatments as safety and efficacy have not been established in this age group.

    Bed-wetting at night

    • An ECG should be performed prior to initiating

      therapy with Amitriptyline to exclude long QT syndrome

    • This medicines should not be taken at the same

      time as an anticholinergic drug (see also section 2, “Other medicines and Amitriptyline Tablets”)

    • Suicidal thoughts and behaviours may also develop

      during early treatment with antidepressants for disorders other than depression; the same precautions observed when treating patients with depression should therefore be followed when treating patients with enuresis.

Other medicines and Amitriptyline Tablets

Some medicines may affect the action of other medicines and this can sometimes cause serious side effects. Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, such as:

  • monoamine oxidase inhibitors (MAOIs) e.g.

    phenelzine, iproniazid, isocarboxazid, nialamide or tranylcypromine (used to treat depression) or selegiline (used to treat Parkinson's disease). These should not be taken at the same time as Amitriptyline Tablets (see section 2, “Do not take Amitriptyline Tablets”)

  • adrenaline, ephedrine, isoprenaline, noradrenaline,

    phenylephrine and phenylpropanolamine (these may be present in cough or cold medicine, and in some anaesthetics)

  • medicine to treat high blood pressure for example

    calcium-channel blockers (e.g. diltiazem and verapamil), guanethidine, betanidine, clonidine reserpine and methyldopa

  • anticholinergic drugs such as certain medicines to

    treat Parkinsons disease and gastrointerstinal disorders (e.g. atropine, hyoscyamine)

  • thioridazine (used to treat schizophrenia)
  • tramadol (painkiller)
  • medicines to treat fungal infections (e.g. fluconazole,

    terbinafine, ketoconazole, and itraconazole)

  • sedatives (e.g. babiturates)
  • antidepressants (e.g. SSRIs (fluoxetine, paroxetine,

    fluvoxamine), and bupropion)

  • medicines for certain heart conditions

    (e.g. beta blockers and antiarrhythmics)

  • methylphenidate (used to treat ADHD)
  • cimetidine (used to treat stomach ulcers)
  • ritonavir (used to treat HIV)
  • oral contraceptives
  • rifampicin (to treat infections)
  • phenytoin and carbamazepine (used to treat epilepsy)
  • St. John´s Wort (hypericum perforatum) – a herbal

    remedy used for depression

  • thyroid medication
  • valproic acid.

You should also tell your doctor if you take or have recently taken medicine that may affect the heart’s rhythm. e.g.:

  • medicines to treat irregular heartbeats (e.g.

    quinidine and sotalol)

  • astemizole and terfenadine (used to treat allergies

    and hayfever)

  • medicines used to treat some mental illnesses (e.g.

    pimozide and sertindole)

  • cisapride (used to treat certain types of indigestion)
  • halofantrine (used to treat malaria)
  • methadone (used to treat pain and for detoxification)
  • diuretics (“water tablets” e.g. furosemide)

    Some medicines may increase the side effects of Amitriptyline Tablets and may sometimes cause very serious reactions.

    Do not take any other medicines whilst taking Amitriptyline Tablets without first talking to your doctor, especially:

    • buprenorphine or buprenorphine/naloxone - These medicines may interact with Amitriptyline Tablets and you may experience symptoms such as involuntary, rhythmic contractions of muscles, including the muscles that control movement of the eye, agitation, hallucinations, coma, excessive sweating, tremor, exaggeration of reflexes, increased muscle tension, body temperature above 38°C. Contact your doctor when experiencing such symptoms.

If you are going to have an operation and receive general or local anaesthetics, you should tell your doctor that you are taking this medicine.

Likewise, you should tell your dentist that you take this medicine if you are to receive a local anaesthetic.

Amitriptyline Tablets with alcohol

It is not advised to drink alcohol during treatment with this medicine as it might increase the sedative effect.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Amitriptyline is not recommended during pregnancy unless your doctor considers it clearly necessary and only after careful consideration of the benefit and risk. If you have taken this medicine during the last part of the pregnancy, the newborn may have withdrawal symptoms such as irritability, increased muscle tension, tremor, irregular breathing, poor drinking, loud crying, urinary retention, and constipation.

Your doctor will advise you whether to start/continue/ stop breast-feeding, or stop using this medicine taking into account the benefit of breast-feeding for your child and the benefit of therapy for you.

Driving and using machines

This medicine may cause drowsiness and dizziness, especially in the beginning of the treatment. Do not drive or work with tools or machinery if you are affected.

Amitriptyline Tablets contain lactose and sunset yellow

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product, as it contains a type of sugar called lactose.

The 25 mg tablets also contain a colour called 'sunset yellow' which may cause allergic reactions.

3. How to take Amitriptyline Tablets

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Not all dosage schemes can be achieved with all the pharmaceutical forms/strengths. The appropriate formulation/strength should be selected for the starting doses and any subsequent dose increases.

For treatment of depression in:-Adults

The recommended initial dose is 25 mg two times daily. Depending on the response to the medicine, your doctor may gradually increase the dose to 150 mg per day divided in two doses.

Elderly (above 65 years of age) and patients with cardiovascular disease

The recommended initial dose is 10 mg – 25 mg daily. Depending on your response to the medicine, your doctor may gradually increase the dose to a total daily dose of 100 mg divided in two doses. If you receive doses in the range of 100 mg – 150 mg, your doctor may need to do more frequent follow-up with you.

Use in children and adolescents

This medicine should not be given to children or adolescents for treatment of depression. For further information, please, see section 2.

Neuropathic pain, chronic tension type headache and migraine prophylaxis

Your doctor will adjust the medication according to your symptoms and your response to the treatment. Adults

The recommended initial dose is 10 mg - 25 mg in the evening.

The recommended daily dose is 25 mg - 75 mg. Depending on your response to the medicine, your doctor may gradually increase the dose. If you receive doses above 100 mg daily, your doctor may need to do more frequent follow-up with you. Your doctor will instruct you whether to take the doses once daily or divide into two doses.

Elderly (above 65 years of age) and patients with cardiovascular disease

The recommended initial dose is 10 mg – 25 mg in the evening.

Depending on your response to the medicine, your doctor may gradually increase the dose. If you receive doses above 75 mg daily, your doctor may need to do more frequent follow-up with you.

Use in children and adolescents

This medicine should not be given to children or adolescents for treatments of neuropathic pain, chronic tension type headache prophylaxis and migraine prophylaxis. For further information, please, see section 2.

Bed-wetting at night

Use in children and adolescents

The recommended doses for children:

  • aged below 6 years: see section 2, “Do not take

    Amitriptyline Tablets”

  • aged 6 to 10 years: 10 mg – 20 mg daily. A suitable

    dosage form should be used for this age group.

  • aged 11 years and above: 25 mg – 50 mg.

The dose should be increased gradually. Take this medicine 1-1½ hours before bedtime.

Before starting treatment, your doctor will conduct an ECG of your heart to check for sign of unusual heartbeat.

Your doctor will re-evaluate your treatment after 3 months and if needed perform a new ECG.

Do not stop the treatment without consulting your doctor first.

Patients with special risks

Patients with liver diseases or people known as “poor metabolisers” usually receive lower doses. Your doctor may take blood samples to determine the level of Amitriptyline in the blood (see also section 2).

How and when to take Amitriptyline Tablets

This medicine can be taken with or without food. Swallow the tablets with a drink of water. Do not chew them.

Duration of treatment

Do not change the dose of the medicine or stop taking the medicine without consulting your doctor first.

Depression

As with other medicines for the treatment of depression it may take a few weeks before you feel any improvement. In treating depression the duration of treatment is individual, and is usually at least 6 months. The duration of treatment is decided by your doctor.

Continue to take this medicine for as long as your doctor recommends.

The underlying illness may persist for a long time. If you stop your treatment too soon, your symptoms may return.

Neuropathic pain, chronic tension type headache and migraine prophylaxis

It might take a few weeks before your feel any improvement of your pain.

Talk to your doctor about the duration of your treatment and continue to take this medicine for as long as your doctor recommends.

Bed-wetting at night

Your doctor will evaluate if the treatment should be continued after 3 months.

If you take more Amitriptyline Tablets than you should

Contact your doctor or nearest hospital casualty department immediately. Do this even if there are no signs of discomfort or poisoning. Take the container of this medicine with you if you go to a doctor or hospital. Symptoms of overdose include:

  • dilated pupils
  • fast or irregular heartbeats
  • difficulties passing water
  • dry mouth and tongue
  • intestinal blockage
  • fits
  • fever
  • agitation
  • confusion
  • hallucinations
  • uncontrolled movements
  • low blood pressure, weak pulse, pallor
  • difficulty breathing
  • blue discolouration of the skin
  • decreased heart rate
  • drowsiness
  • loss of consciousness
  • coma
  • various cardiac symptoms such as heart block, heart failure, hypotension, cardiogenic shock, metabolic acidosis, hypokalemia.

Overdose with Amitriptyline Tablets in children could have serious consequences. Children are especially susceptible to coma, cardiac symptoms, difficulty in breathing, seizures, low blood sodium level, lethargy, drowsiness, nausea, vomiting and high blood sugar level.

If you forget to take Amitriptyline Tablets

If you forget to take a dose, take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.

If you stop taking Amitriptyline Tablets

Your doctor will decide when and how to stop your treatment to avoid any unpleasant symptoms that might occur if it is stopped abruptly (e.g. headache, feeling unwell, sleeplessness and irritability).

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking Amitriptyline Tablets and contact your doctor at once if you experience the following:

  • Attacks of intermittent blurring of vision, rainbow vision, and eye pain. You should immediately have an eye examination before the treatment with this medicine can be continued. This condition may be signs of acute glaucoma.
  • signs of a severe allergic reaction (anaphylaxis) such as swelling of your tongue or face, or difficulty breathing.

    Very rare side effect, may affect up to 1 in 10,000 people.

  • A heart problem called “prolonged QT interval”

    (which is shown on your electrocardiogram, ECG). Common side effect, may affect up to 1 in 10 people.

  • Bad constipation, a swollen stomach, fever and vomiting. These symptoms may be due to parts of the intestine becoming paralysed.

    Rare side effect, may affect up to 1 in 1,000 people.

  • Any yellowing of the skin and the white in the eyes

    (jaundice). Your liver may be affected.

    Rare side effect, may affect up to 1 in 1,000 people.

  • Bruising, bleeding, pallor or persistent sore throat and fever. These symptoms can be the first signs that your blood or bone marrow may be affected. Effects on the blood could be a decrease in the number of red cells (which carry oxygen around the
  • hot flush
  • dry eyes
  • widespread rash, high body temperature and

    enlarged lymph nodes (DRESS or drug hypersensitivity syndrome).

An increased risk of bone fractures has been observed in patients taking this type of medicines.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Amitriptyline Tablets

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton or the pack. The expiry date refers to the last day of that month.

Store in the original container or packaging. Do not store above 25°C.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicine you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Amitriptyline Tablets contain

The active substance is Amitriptyline hydrochloride.

Each tablet contains 25 mg of active ingredient Amitriptyline hydrochloride.

The other inactive ingredients are Lactose monohydrate, maize starch, povidone, magnesium stearate, stearic acid, hypromellose 5 cP, ethylcellulose 10 cP, diethyl phthalate, isopropyl alcohol, purified water and the colours titanium dioxide (E171), quinoline yellow aluminium lake (E104) and sunset yellow FCF aluminium lake (E110).

What Amitriptyline Tablets look like and contents of the pack

Amitriptyline Tablets are yellow, circular, film-coated tablets with A2 embossed on one side.

The tablets are supplied in blister packs of 28 tablets or pots of 500 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Relonchem Limited,

Cheshire House,

Gorsey Lane, Widnes,

Cheshire, WA8 0RP,

UK.

Product Licence Number: PL 20395/0029.

This leaflet was last revised in June 2026.

PRODUCT NAME PRODUCT LICENCE NO.

DIMENSION STRENGTH PACK SIZE

FONT & SIZE

REMARKS REASON FOR CHANGE

COUNTRY MANUFACTURER

SOFTWARE

ARTIST Amitriptyline 25 mg Tablets

20395-0029

Pil

-

25 mg

-

Humanst521 BT, Heading 15 pt, 12 pt, rest all 9 pt -

Comments recieved from Chaithra on 22.06.2026.

UK (English)

-

Adobe illustrator CC Bhuddish

NO. OF COLORS 01

██ Black

██ Dieline

1.5

VERSION Mock up DATE 22.06.2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 20395/0029

Last revision stated in the text: June 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Amitriptyline 25 mg tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Amitriptyline
Strength 25 mg
Pharmaceutical form Oral tablet
Appearance: Yellow, circular, biconvex, film coated tablet with A2 embossed on one side.
How is it taken Oral
Excipients Lactose monohydrate, Povidone, Magnesium stearate, Stearic acid, Maize starch, Titanium dioxide (E171), Quinoline yellow aluminium lake (E104), Sunset yellow aluminium lake (E110), Hypromellose 5 cP, Ethylcellulose 10 cP, Diethyl Phthalate, Hydroxypropyl Cellulose, Isopropyl Alcohol, Purified water
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Tablet Containers: 3 years.
Blisters: 3 years.
Storage Tablet Containers: Do not store above 25°C. Store in the original container.
Keep the container tightly closed.
Blisters: Do not store above 25°C. Store in original packaging.
Drug group (ATC) Antidepressants - Non-selective monoamino reuptake inhibitor (Tricyclic Antidepressants)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06A Antidepressants
        1. N06AA Non-selective monoamine reuptake inhibitors
          1. N06AA09 amitriptyline
Marketing authorisation PL 20395/0029 (first authorised 11 December 2008)
Marketing authorisation holder Relonchem Limited
Codes BNF 04030100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.